These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11179057)

  • 1. Gender and aging in a transgenic mouse model of hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Leinwand LA; Moore RL
    Am J Physiol Heart Circ Physiol; 2001 Mar; 280(3):H1136-44. PubMed ID: 11179057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy.
    Olsson MC; Palmer BM; Stauffer BL; Leinwand LA; Moore RL
    Circ Res; 2004 Feb; 94(2):201-7. PubMed ID: 14670849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of beta-myosin heavy chain expression on cardiac function during stress.
    Krenz M; Robbins J
    J Am Coll Cardiol; 2004 Dec; 44(12):2390-7. PubMed ID: 15607403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy associated Lys104Glu mutation in the myosin regulatory light chain causes diastolic disturbance in mice.
    Huang W; Liang J; Kazmierczak K; Muthu P; Duggal D; Farman GP; Sorensen L; Pozios I; Abraham TP; Moore JR; Borejdo J; Szczesna-Cordary D
    J Mol Cell Cardiol; 2014 Sep; 74():318-29. PubMed ID: 24992035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.
    Spindler M; Saupe KW; Christe ME; Sweeney HL; Seidman CE; Seidman JG; Ingwall JS
    J Clin Invest; 1998 Apr; 101(8):1775-83. PubMed ID: 9541509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput phenotyping of left and right ventricular cardiomyopathy in calcineurin transgene mice.
    Moreth K; Afonso LC; Fuchs H; Gailus-Durner V; Katus HA; Bekeredjian R; Lehman L; Hrabě de Angelis M
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):669-79. PubMed ID: 25627778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model of familial hypertrophic cardiomyopathy.
    Geisterfer-Lowrance AA; Christe M; Conner DA; Ingwall JS; Schoen FJ; Seidman CE; Seidman JG
    Science; 1996 May; 272(5262):731-4. PubMed ID: 8614836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.
    Lowey S; Lesko LM; Rovner AS; Hodges AR; White SL; Low RB; Rincon M; Gulick J; Robbins J
    J Biol Chem; 2008 Jul; 283(29):20579-89. PubMed ID: 18480046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2.
    Sørensen LL; Bedja D; Sysa-Shah P; Liu H; Maxwell A; Yi X; Pozios I; Olsen NT; Abraham TP; Abraham R; Gabrielson K
    Comp Med; 2016; 66(4):268-77. PubMed ID: 27538857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy.
    Petersen HH; Choy J; Stauffer B; Moien-Afshari F; Aalkjaer C; Leinwand L; McManus BM; Laher I
    Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2244-9. PubMed ID: 12388227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of familial hypertrophic cardiomyopathy: early and evolving effects from an alpha-cardiac myosin heavy chain missense mutation.
    Georgakopoulos D; Christe ME; Giewat M; Seidman CM; Seidman JG; Kass DA
    Nat Med; 1999 Mar; 5(3):327-30. PubMed ID: 10086390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two murine models of familial hypertrophic cardiomyopathy.
    McConnell BK; Fatkin D; Semsarian C; Jones KA; Georgakopoulos D; Maguire CT; Healey MJ; Mudd JO; Moskowitz IP; Conner DA; Giewat M; Wakimoto H; Berul CI; Schoen FJ; Kass DA; Seidman CE; Seidman JG
    Circ Res; 2001 Mar; 88(4):383-9. PubMed ID: 11230104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
    Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal gene transfer of Serca2a delays onset of hypertrophic remodeling and improves function in familial hypertrophic cardiomyopathy.
    Peña JR; Szkudlarek AC; Warren CM; Heinrich LS; Gaffin RD; Jagatheesan G; del Monte F; Hajjar RJ; Goldspink PH; Solaro RJ; Wieczorek DF; Wolska BM
    J Mol Cell Cardiol; 2010 Dec; 49(6):993-1002. PubMed ID: 20854827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophic cardiomyopathy R403Q mutation in rabbit β-myosin reduces contractile function at the molecular and myofibrillar levels.
    Lowey S; Bretton V; Joel PB; Trybus KM; Gulick J; Robbins J; Kalganov A; Cornachione AS; Rassier DE
    Proc Natl Acad Sci U S A; 2018 Oct; 115(44):11238-11243. PubMed ID: 30322937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
    Nagueh SF; Chen S; Patel R; Tsybouleva N; Lutucuta S; Kopelen HA; Zoghbi WA; Quiñones MA; Roberts R; Marian AJ
    J Mol Cell Cardiol; 2004 May; 36(5):663-73. PubMed ID: 15135661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.